Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- HIV -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (17)	9/8/2005 12:51:09 PM
From: scaram(o)uche	Respond to of 155

russet's posts often focus on the experimental system and what it may tell us about biology. I'd much rather see the stuff he digs up than not. That said, I believe that all biotech threads should be moderated. :-)

To: tuck who wrote (17)	9/9/2005 12:14:23 AM
From: russet	Read Replies (1) \| Respond to of 155

I live in Canada, and read Canadian newswires to make money on stocks (full time job in itself),...but I attempt to publish only science information on these indication threads, and nothing is meant to be company or person specific. I look for things of interest to biologists and science lovers of all types and let it rip. If we can't tolerate each others nationalities, customs, physical and social differences, beliefs etc., how can we ever fit harmoniously into the universe? I'm certainly not Canada-centric in anything but where I live. I try to be an Earthling first. Two important debates in aids research have been,...are vaccines worth anything?,...and do aids victims have to take the side effect rich drugs non-stop forever, or can they take a break? Both issues are addressed in the research cited in my post. Innocent until proven guilty, unless moderated out of existence :-)

To: tuck who wrote (17)	9/9/2005 12:14:23 AM
From: russet	Respond to of 155

SI glitch gave me a double post,...bummer. Did a google search and came up with this site,... hivinsite.ucsf.edu And this article,... HIV-AIDS vaccine still long way off CP 2005-09-08 02:20:17 MONTREAL -- The handful of potential HIV-AIDS vaccines close to full-scale clinical trials in humans are unlikely to provide a silver bullet to beat the disease within the next decade, an AIDS researcher said yesterday. Seventeen years after the first vaccine tests were done on people, the race for a vaccine remains "five miles into a 26-mile marathon," Michael Keefer said. However, Keefer is optimistic a partially effective vaccine might appear in the next few years that could provide a starting point for the final push for a vaccine effective against all strains of AIDS. "There is a chance if we're very lucky that could be within 10 years maybe, but none of us is expecting to get lucky in this," said Keefer, a professor of medicine at the University of Rochester in New York state. Keefer was attending an international conference on research into finding a vaccine for HIV-AIDS. He has been involved in clinical trials since the first attempts to create such vaccinations in 1988. "I'm certain that some day we'll have a preventive vaccine that will put HIV where smallpox is today. I'm not going to say it's going to be in 10 years or 20 years or 50 years," he said. "I would say a partially effective vaccine in the mid-term future and then constantly improving on that is the likely scenario." Faced with constantly evolving scientific hurdles that lead to waves of hope and pessimism, the search for a vaccine to prevent HIV-AIDS infections has recently faced a new squeeze on funding. After years of record increases, funding agencies in the U.S. and Canada have frozen or cut budgets in 2005. Copyright © The London Free Press